SPOTLIGHT -
Slideshow
Author(s):
A novel protocol lights the way for a promising treatment for bipolar depression.
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia
Blue Light, Depression, and Bipolar Disorder
BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial
Four Myths About Lamotrigine
FDA Accepts sNDA for Uzedy Extended-Release Injectable Suspension for Bipolar I Disorder
Bipolar Disorder Research Roundup: February 18, 2025